Goldenstone Acq (NASDAQ:GDSTU) Stock, Quote.Headers.trade-ideas

Goldenstone Acquisition Ltd is a newly organized blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Goldenstone Acquisition Ltd

Germany is facing a sharp downturn <a href="https://www.benzinga.com/topic/manufacturing">in its manufacturing sector</a>.
What Happened: New orders for German manufacturing fell by 5.8% month-over-month in August, <a href="https://www.destatis.de/EN/Press/2024/10/PE24_381_421.html">according</a> to data from the German Destatis. This was <a href="https://www.benzinga.com/news/24/09/40748511/volkswagens-battery-plant-in-germany-to-operate-at-reduced-capacity-amid-financial-strains">a deeper-than-expected decline</a> — much larger than the 2% drop <a href="https://www.bloomberg.com/news/articles/2024-10-07/german-factory-orders-drop-in-yet-another-sign-of-industry-woe?utm_source=website&amp;utm_medium=share&amp;utm_campaign=twitter?sref=R17xFhjo">forecasted</a> by Bloomberg economists. 
Economists attributed the magnitude of the decline to a robust July marked by large orders.
&#8220;One of the reasons for the negative development of new orders in August 2024 were the very large orders for other transport equipment (manufacture of aircraft, ships, trains, military vehicles) placed in the previous month,&#8221; the statement read. &#8220;When large-scale orders are excluded, new orders in August 2024 were only 3.4% lower than in July 2024.&#8221;
German GDP fell by 0.1% in 2024&#8217;s second quarter, <a href="https://www.destatis.de/EN/Press/2024/07/PE24_289_811.html">according</a> to a July statement from Destatis. Investors are pessimistic too —&nbsp;economic sentiment has markedly <a href="https://www.zew.de/en/press/latest-press-releases/expectations-break-down">fallen</a> in the second half of 2024, according to ZEW.
Why it Matters: The data is a worrying sign for German manufacturing&#8217;s stability, which could have a ripple effect beyond Europe.
Germany will release industrial production data on Tuesday followed by economic forecasts on Wednesday.
The German economy has struggled since long-time Chancellor Angela Merkel departed from government in 2021. Her successor, the center-left Olaf Scholz, has <a href="https://www.benzinga.com/news/24/08/40369565/germany-reportedly-issues-arrest-warrant-against-ukrainian-diver-in-nord-stream-pipeline-sabotage">overseen Germany&#8217;s response</a> to the Russian invasion of Ukraine.
The decline comes amid a possible trade war between the European Union and China over electric vehicles. 
Car manufacturer Volkswagen AG&#8216;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) faces <a href="https://www.benzinga.com/news/24/09/40748511/volkswagens-battery-plant-in-germany-to-operate-at-reduced-capacity-amid-financial-strains">possible plant closures</a>. The share price of Volkswagen and fellow German automakers Bayerische Motoren Werke (BMW) AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BAMXF#OTC">BAMXF</a>) and Mercedes Benz Group ADR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MBGYY#OTC">MBGYY</a>) have struggled mightily in the past year.
The iShares MSCI Germany ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWG#NYSE">EWG</a>), which tracks the German market, is nearly even since 2022. The Europe-tracking Vanguard European Stock Index Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VGK#NYSE">VGK</a>) is up just 2%, paltry compared to the United States SPDR S&amp;P 500 ETF Trust&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) 20% return in that period.
It is possible that Germany&#8217;s slowdown can affect U.S. equities. U.S. companies that do business with German firms, or rely on Germany for key components, could face disruptions. Likewise, a weakened European economy may lead to reduced consumer demand for U.S. goods and services, particularly in sectors like luxury goods, travel, and technology.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41178306/germany-home-to-mercedes-and-bmw-set-to-oppose-eu-tariffs-on-chinese-evs-report">Germany, Home To Mercedes And BMW, Set To Oppose EU Tariffs On Chinese EVs: Report</a></li>
</ul>
Image: Shutterstock

Equities

Eurozone

Global

ETFs

BAMXF

MERCEDES-BENZ UNSP / ADR by Mercedes Benz Group AG

MBGYY

VWAGY

Germany's Manufacturing, Economic Engine Falters: Why US Investors Should Care

<h3 class="wp-block-heading">Curaleaf</h3>
Curaleaf Holdings, Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CURA#TSX">CURA</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTCQX">CURLF</a>) will report its financial and operating results for the third quarter that ended Sept. 30, 2024 after market close on Nov. 6, 2024.
The cannabis giant said it would host a conference call and audio webcast on the same day at 5:00 pm Eastern Time.
Curaleaf <a href="https://www.benzinga.com/markets/cannabis/24/08/40238621/curaleaf-posts-48-9m-loss-in-q2-what-it-means-for-your-cannabis-investments">reported</a> its second-quarter financials in August, revealing revenue of $342 million, up by 2% from the same quarter of the previous year. The company also reported a net loss of $48.9 million for the quarter, marking a per-share loss of $0.06.
Nevertheless, the company has continued to actively expand its global and domestic footprint.<a href="https://www.benzinga.com/markets/cannabis/24/06/39256772/beyond-europe-and-north-america-curaleaf-ceo-on-cannabis-markets-in-australia-new-zealand-and-is"> Internationally,</a> revenue surged by 78% for the second quarter, driven by robust <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39609582/europe-is-turning-cash-flow-positive-well-see-what-happens-in-the-u-s-largest-canna">performance in the UK and Germany.</a>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/07102458/ccc-oct-24-banner__1_-12.gif" alt="" class="wp-image-583621" /></a></figure>
The company has also recognized the potential of Poland&#8217;s medical marijuana market, as its subsidiary, Curaleaf International, expanded in the European country this year via the <a href="https://www.benzinga.com/markets/cannabis/24/02/36958982/cannabis-giant-curaleaf-expands-in-this-european-country-via-new-acquisition">acquisition of Can4Med</a>, a pharmaceutical wholesaler <a href="https://www.benzinga.com/markets/cannabis/24/09/40693857/two-european-marijuana-companies-team-up-to-bring-cannabis-based-solutions-to-poland">specializing in cannabinoid medication.</a>
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39609582/europe-is-turning-cash-flow-positive-well-see-what-happens-in-the-u-s-largest-canna">Europe Is Turning Cash Flow Positive, &#8216;We&#8217;ll See What Happens In The U.S.,&#8217; Says Curaleaf&#8217;s Boris Jordan</a> 
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
Curaleaf <a href="https://www.benzinga.com/markets/cannabis/24/08/40257584/cannabis-mogul-boris-jordan-to-take-the-reins-at-marijuana-giant-curaleaf">named its executive</a> chairman Boris Jordan as the new CEO in August, after Matt Darin announced <a href="https://www.benzinga.com/markets/cannabis/24/08/40487167/ceo-shake-ups-at-canopy-curaleaf-and-recent-top-exec-and-board-changes-in-cannabis-and-psychedel">his retirement plans.</a>
Jordan is one of the keynote speakers at the upcoming Benzinga event in Illinois. Come, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices surge by following <a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.
Curaleaf's shares traded 0.67% lower at $2.96 per share at the time of writing on Monday morning.
<h3 class="wp-block-heading">MariMed</h3>
MariMed Inc. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#CSE">MRMD</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MRMD#OTCQX">MRMD</a>) will report third-quarter financial results on Nov. 6, 2024, after the markets close. Management will host a conference call the next day at 8:00 am Eastern Time.
The multi-state cannabis operator disclosed its financial results for the second quarter, which ended June 30, 2024, in August, revealing revenue of $40.4 million, compared to $36.5 million in the same period last year.
Jon Levine, who is also among the slew of experts and entrepreneurs slated to speak at this week's Benzinga Cannabis Conference in Chicago,<a href="https://www.benzinga.com/markets/cannabis/24/08/40250157/marimed-revenue-grows-10-7-qoq-hires-new-cfo-and-remains-on-track-to-deliver-2024-financial-targ"> said at the time</a> that MariMed management team is "confident we will realize margin expansion and increased cash flow long-term as our new assets deliver their full revenue potential.&#8221;
During the second quarter, the company <a href="https://www.benzinga.com/markets/cannabis/24/04/38203791/marimed-is-on-a-roll-partners-with-two-iconic-music-venues-in-boston-acquires-another-illinois-c">closed the acquisition of</a><a href="https://www.benzinga.com/markets/cannabis/24/04/38203791/marimed-is-on-a-roll-partners-with-two-iconic-music-venues-in-boston-acquires-another-illinois-c"> Allgreens Dispensary,</a> its fifth dispensary in Illinois.
MariMed's shares traded 4.40% lower at $0.152 per share at the time of writing on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/04/38303746/a-f-ed-up-situation-says-marimed-cco-about-how-state-regulations-complicate-cannabis-edibles-str">&#8216;A F—ed-Up Situation,&#8217; Says MariMed CCO About How State Regulations Complicate Cannabis Edibles Strategy</a></li>
</ul>

Cannabis

Earnings

News

Events

CSE:MRMD

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

MRMD

TSX:CURA

These Two Marijuana Giants Will Soon Report Earnings, Hear From CEOs At Benzinga Cannabis Conference

Whales with a lot of money to spend have taken a noticeably bullish stance on Walt Disney.
Looking at options history for Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) we detected 15 trades.
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 46% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $403,422 and 11, calls, for a total amount of $531,075.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $80.0 and $110.0 for Walt Disney, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Walt Disney stands at 5183.77, with a total volume reaching 7,325.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Walt Disney, situated within the strike price corridor from $80.0 to $110.0, throughout the last 30 days.
<h3>Walt Disney Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728315074_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/08/24</td>
<td>$0.7</td>
<td>$0.64</td>
<td>$0.68</td>
<td>$86.00</td>
<td>$238.0K</td>
<td>33</td>
<td>3.5K</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$11.5</td>
<td>$11.0</td>
<td>$11.3</td>
<td>$100.00</td>
<td>$135.6K</td>
<td>3.5K</td>
<td>120</td>
</tr>
<tr>
<td>DIS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$7.25</td>
<td>$7.15</td>
<td>$7.25</td>
<td>$95.00</td>
<td>$100.7K</td>
<td>317</td>
<td>139</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/18/24</td>
<td>$1.43</td>
<td>$1.31</td>
<td>$1.36</td>
<td>$95.00</td>
<td>$73.1K</td>
<td>11.0K</td>
<td>562</td>
</tr>
<tr>
<td>DIS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$10.85</td>
<td>$10.65</td>
<td>$10.7</td>
<td>$100.00</td>
<td>$64.2K</td>
<td>3.5K</td>
<td>205</td>
</tr>
</tbody>
</table>

<h3>About Walt Disney</h3>
Disney operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from franchises and characters the firm has created over the course of a century. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses ESPN and the ESPN+ streaming service. Experiences contains Disney's theme parks and vacation destinations, and also benefits from merchandise licensing.
After a thorough review of the options trading surrounding Walt Disney, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Walt Disney's Current Market Status</h3>
<ul>
<li>With a trading volume of 2,189,917, the price of DIS is down by -1.94%, reaching $93.31.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 38 days from now.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Walt Disney, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Walt Disney Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PATH, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for UiPath.
This isn't normal.
The overall sentiment of these big-money traders is split between 62% bullish and 25%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $156,000, and 2 are calls, for a total amount of $106,400.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $12.5 to $25.0 for UiPath over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for UiPath's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of UiPath's whale activity within a strike price range from $12.5 to $25.0 in the last 30 days. 
<h3>UiPath 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728315069_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.69</td>
<td>$1.41</td>
<td>$1.41</td>
<td>$17.50</td>
<td>$56.4K</td>
<td>4.6K</td>
<td style="text-align: right;">500</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$0.7</td>
<td>$0.4</td>
<td>$0.5</td>
<td>$25.00</td>
<td>$50.0K</td>
<td>5.4K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>PATH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.74</td>
<td>$2.57</td>
<td>$2.6</td>
<td>$12.50</td>
<td>$26.0K</td>
<td>7.9K</td>
<td style="text-align: right;">938</td>
</tr>
<tr>
<td>PATH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.82</td>
<td>$2.57</td>
<td>$2.6</td>
<td>$12.50</td>
<td>$26.0K</td>
<td>7.9K</td>
<td style="text-align: right;">638</td>
</tr>
<tr>
<td>PATH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$2.7</td>
<td>$2.56</td>
<td>$2.6</td>
<td>$12.50</td>
<td>$26.0K</td>
<td>7.9K</td>
<td style="text-align: right;">538</td>
</tr>
</tbody>
</table>

<h3>About UiPath</h3>
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
<h3>UiPath's Current Market Status</h3>
<ul>
<li>With a volume of 1,657,785, the price of PATH is down -2.2% at $12.21. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 53 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest UiPath options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

PATH

UiPath's Options Frenzy: What You Need to Know

Whales with a lot of money to spend have taken a noticeably bullish stance on Arista Networks.
Looking at options history for Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 37% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $57,580 and 6, calls, for a total amount of $300,840.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $500.0 for Arista Networks during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Arista Networks's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Arista Networks's significant trades, within a strike price range of $100.0 to $500.0, over the past month.
<h3>Arista Networks Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728315063_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$74.7</td>
<td>$65.2</td>
<td>$74.7</td>
<td>$500.00</td>
<td>$74.7K</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$84.3</td>
<td>$81.8</td>
<td>$82.9</td>
<td>$400.00</td>
<td>$74.6K</td>
<td style="text-align: right;">136</td>
<td style="text-align: right;">12</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$36.1</td>
<td>$34.8</td>
<td>$34.8</td>
<td>$390.00</td>
<td>$52.2K</td>
<td style="text-align: right;">223</td>
<td style="text-align: right;">11</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$36.1</td>
<td>$32.9</td>
<td>$34.82</td>
<td>$400.00</td>
<td>$34.8K</td>
<td style="text-align: right;">557</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$35.5</td>
<td>$34.2</td>
<td>$34.8</td>
<td>$390.00</td>
<td>$34.8K</td>
<td style="text-align: right;">223</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
Following our analysis of the options activities associated with Arista Networks, we pivot to a closer look at the company's own performance.
<h3>Arista Networks's Current Market Status</h3>
<ul>
<li>With a trading volume of 435,982, the price of ANET is up by 0.74%, reaching $398.9.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 21 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Arista Networks</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $418.3333333333333.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Evercore ISI Group persists with their Outperform rating on Arista Networks, maintaining a target price of $400. 
&#x2A; Consistent in their evaluation, an analyst from Goldman Sachs keeps a Buy rating on Arista Networks with a target price of $430. 
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Arista Networks, targeting a price of $425. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Arista Networks with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

ANET

Check Out What Whales Are Doing With ANET

Potential Label Expansion To Include Rapid Induction And Alternative Injection Sites In Thigh, Buttock, And Back Of Arm

Biotech

General

INDV

Indivior's SUBLOCADE Prior Approval Supplement Receives FDA Priority Review With PDUFA Date Set For Feb 7, 2025

Cantor Fitzgerald analyst Deepak Mathivanan reiterates Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) with a Neutral and maintains $340 price target.

Price Target

Reiteration

Analyst Ratings

SPOT

Cantor Fitzgerald Reiterates Neutral on Spotify Technology, Maintains $340 Price Target

Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) has outperformed the market over the past 10 years by 11.17% on an annualized basis producing an average annual return of 22.95%. Currently, Lennox Intl has a market capitalization of $21.17 billion. 
Buying $1000 In LII: If an investor had bought $1000 of LII stock 10 years ago, it would be worth $7,992.53 today based on a price of $594.05 for LII at the time of writing.
<h3>Lennox Intl's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728315020_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 10 Years Ago Would Be Worth $8,000 Today

American Tower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMT#NYSE">AMT</a>) has outperformed the market over the past 20 years by 5.48% on an annualized basis producing an average annual return of 14.03%. Currently, American Tower has a market capitalization of $104.15 billion. 
Buying $100 In AMT: If an investor had bought $100 of AMT stock 20 years ago, it would be worth $1,376.45 today based on a price of $222.99 for AMT at the time of writing.
<h3>American Tower's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728315015_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In American Tower 20 Years Ago Would Be Worth Today

CleanSpark Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) shares are trading lower Monday despite a rise in the price of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>). Here&#8217;s a look at <a href="https://www.benzinga.com/pressreleases/24/10/n41206325/cleanspark-reaches-28-7-ehs-in-hashrate">what you need to know</a>.
What To Know: Bitcoin is up more than 2.3% over the past 24-hours, leading the broader crypto space and several crypto-related stocks higher, but CleanSpark shares are not participating in the move. 
CleanSpark on Monday said that normal operations had resumed across its facilities after 365 MW of power was shut down in the wake of <a href="https://www.benzinga.com/news/24/10/41110256/hurricane-helene-claims-128-lives-across-6-states-and-millions-struggle-without-power-north-carolina">Hurricane Helene</a>.
The update comes after the Bitcoin mining company announced last week that it shut down some of the power at its Southeast Georgia&nbsp;sites as the hurricane began impacting the region. CleanSpark noted at the time that it was able to maintain approximately 10.5 EH/s at its mining sites&nbsp;throughout the storm.
CleanSpark said it was able to bring its hashrate up to 17.5 EH/s within 24 hours of the storm. As of Monday, the company&#8217;s hash rate was at 28.7 EH/s. The company recently said it experienced no material damage to its site infrastructure and was&nbsp;not aware of any material losses related to mining servers.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41190083/us-labor-market-posts-strong-data-what-it-means-for-bitcoin">US Labor Market Posts Strong Data—What It Means For Bitcoin</a>
CleanSpark also reported monthly mining metrics last week showing that it mined 493 Bitcoin in September, up from 478 in August. The company has now mined a total of 5,079 Bitcoin year-to-date. CleanSpark&#8217;s total&nbsp;Bitcoin&nbsp;holdings were up to 8,049 as of Sept. 30.
CleanSpark is targeting 30 EH/s in October and plans to grow to 50 EH/s and beyond in 2025. 
CLSK Price Action: <a href="http://benzinga.com/quote/clsk">CleanSpark shares</a> were down 2.19% at $9.37 at the time of publication Monday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

$BTC

CLSK

What's Going On With CleanSpark Stock Today?

B. Riley Securities analyst Eric Wold reiterates United Parks &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRKS#NYSE">PRKS</a>) with a Buy and maintains $71 price target.

PRKS

B. Riley Securities Reiterates Buy on United Parks & Resorts, Maintains $71 Price Target

UBS analyst Jonathan Yong initiates coverage on Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) with a Neutral rating and announces Price Target of $23.

Initiation

OSCR

UBS Initiates Coverage On Oscar Health with Neutral Rating, Announces Price Target of $23

B. Riley Securities analyst Mayank Mamtani reiterates Trevi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVI#NASDAQ">TRVI</a>) with a Buy and maintains $6 price target.

TRVI

B. Riley Securities Reiterates Buy on Trevi Therapeutics, Maintains $6 Price Target

Macro Notification

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Lebanon's Hezbollah Says It Targeted North Of Israel's Haifa With A Missile Salvo

B. Riley Securities analyst Lucas Pipes maintains TeraWulf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WULF#NASDAQ">WULF</a>) with a Buy and maintains $6 price target.

WULF

B. Riley Securities Maintains Buy on TeraWulf, Maintains $6 Price Target

UBS analyst Peter Grom downgrades Hershey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) from Buy to Neutral and lowers the price target from $226 to $209.

Downgrades

UBS Downgrades Hershey to Neutral, Lowers Price Target to $209

B. Riley Securities analyst Lucas Pipes maintains CONSOL Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEIX#NYSE">CEIX</a>) with a Buy and raises the price target from $109 to $138.

CEIX

B. Riley Securities Maintains Buy on CONSOL Energy, Raises Price Target to $138

Gran Tierra Energy&nbsp;Inc. ("Gran Tierra")&nbsp;(NYSE:<a href="https://www.benzinga.com/stock/GTE#NYSE">GTE</a>) (TSX:<a href="https://www.benzinga.com/stock/GTE#TSX">GTE</a>) (LSE:GTE)&nbsp;today announced that the shareholders of i3 Energy plc, a public limited company organized under the laws of England and Wales ("i3 Energy"), have approved Gran Tierra's previously announced acquisition of i3 Energy (the "Acquisition"). &nbsp;
This approval satisfies one of the conditions to the closing of the Acquisition. The Acquisition remains subject to the satisfaction of additional regulatory closing conditions, as previously disclosed, and is expected to be effective on or about October 31, 2024.

Gran Tierra Energy Acquisition Of i3 Energy Approved By i3 Energy Shareholders

Galecto Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLTO#NASDAQ">GLTO</a>) shares are trading lower by 27% to $8.50 during Monday&#8217;s session. The company issued 62,594 shares of common stock and 160,562 of preferred convertible shares to Bridge Medicine as part of their acquisition for the rights to <a href="https://www.benzinga.com/pressreleases/24/10/g41206069/galecto-completes-strategic-review-to-focus-on-oncology-and-liver-disease-and-acquires-acute-myelo">BRM-1420</a>.
What Happened: Galecto announced a strategic shift to focus on cancer and liver disease, particularly leveraging its clinical-stage asset GB1211, which the company says has shown positive results in non-small cell lung cancer (NSCLC) and cirrhosis studies. 
To strengthen its pipeline, Galecto has acquired global rights to BRM-1420, a novel drug developed by Bridge Medicines, a company co-founded by Takeda. Galecto says BRM-1420 has shown promise in treating genetic subsets of acute myeloid leukemia (AML) and could enhance standard therapies.
In exchange for the rights to BRM-1420, Galecto issued shares representing 4.99% of its outstanding common stock to Bridge Medicines, along with preferred shares that could convert to an additional 12.8% of common stock upon stockholder approval. 
Matthew Kronmiller, CEO of Bridge Medicines, will join Galecto as Executive Vice President of Strategy and Chief Business Officer. The transaction was approved by both companies&#8217; boards, with Leerink Partners advising Galecto and Lazard advising Bridge Medicines.
Read Also: <a href="https://www.benzinga.com/markets/equities/24/10/41207490/s-p-500-could-reach-6-300-in-12-months-says-goldman-sachs-driven-by-strong-ai-demand-and-margin-">S&amp;P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By &#8216;Strong AI Demand&#8217; And &#8216;Margin Expansion&#8217;</a>
<h2 class="wp-block-heading">How To Buy GLTO Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Galecto&#8217;s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, GLTO has a 52-week high of $23.50 and a 52-week low of $8.45.

GLTO

Why Galecto (GLTO) Shares Are Down 27% Today

Cantor Fitzgerald analyst Deepak Mathivanan reiterates Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) with a Neutral and maintains $8 price target.

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

Goldenstone Acq

Goldenstone Acq (GDSTU) Forecast

Goldenstone Acq (NASDAQ:GDSTU) Stock, Quote.Headers.trade-ideas